A Study of Two Doses of Dulaglutide (LY2189265) in Japanese Patients With Type 2 Diabetes

Nakayama Clinic, Nagoya

Tosaki Clinic for Diabetes and Endocrinology, Nagoya

Kashiwa City Hospital, Kashiwa

Kobari General Clinic, Noda

Nippon Kokan Fukuyama Hospital, Fukuyama-shi

Yamagata Naika Clinic, Asahikawa

Hasegawa Medical Clinic, Chitose

Yuri Ono Clinic, Sapporo

Manda Memorial Hospital, Sapporo

Miyanosawa Clinic of Internal Medicine and Cardiology, Sapporo

Takabe Diabetes Clinic, Himeji

Nakamoto Internal Medicine Clinic, Mito

Nakakinen clinic, Naka

Nishiyamadou Keiwa Hospital, Naka

Hayashi Diabetes Internal Medicine Clinic, Chigasaki

Shonan Takai Clinic, Kamakura

Takai Internal Medicine Clinic, Kamakura-shi

Yamagishi Clinic Sagamiono, Sagamihara

Medical Corporation Yuga Tsuruma Kaneshiro Diabetes Clinic, Yamato-shi

Seiryo Internal Medicine, Iwanuma

Gibo Hepatology Clinic, Matsumoto

Shiraiwa Medical Clinic, Kashihara

Medical Corporation Heishinkai OCROM Clinic, Suita-shi

Sugiura Internal Medicine Clinic, Sōka

Seiwa Clinic, Adachi-ku

Tokyo-Eki Center-building Clinic, Chuo-ku

Medical Corporation Chiseikai Tokyo Center Clinic, Chuo-ku

Fukuwa Clinic, Chuo-ku

Hachioji Diabetes Clinic, Hachiōji

Minamino Cardiovascular Hospital, Hachiōji

Yutenji Medical Clinic, Meguro-ku

Kanno Naika, Mitaka

Heishinkai Medical Group ToCROM Clinic, Shinjuku-ku

Nomura Clinic, tabashi City

Futata Tetsuhiro Clinic, Fukuoka

Yoshimura Clinic, Kumamoto

Jinnouchi Hospital, Kumamoto

Heiwadai Hospital, Miyazaki

Ota Diabetes Internal Medicine Clinic, Nagano

AMC Nishiumeda Clinic, Osaka

Kitada Clinic, Osaka

Osaka Metropolitan Univ Hosp, Osaka

Nanko Clinic, Osaka

Abe Clinic, Ōita